VAERS 2398096
GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge 3PN2B
- Staat
- MI
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 01.08.2022
- Impfdatum
- 21.10.2021
- Beginn
- 22.07.2022
- Tage bis Beginn
- 274,0
- Dosis
- N/A
- Route/Site
- - / -
Symptomtext
Discharge Provider: MD Primary Care Provider: MD Admission Date: 7/22/2022 Discharge Date: Jul 26, 2022 PRESENTING PROBLEM: Syncope and collapse [R55] Hypokalemia [E87.6] Total bilirubin, elevated [R17] Stage 3 chronic kidney disease, unspecified whether stage 3a or 3b CKD [N18.30] COVID-19 [U07.1] HOSPITAL COURSE: 59-year-old man with a past medical history significant for atrial fibrillation on Eliquis, Hawkins status post ICD placement, AAA status post repair, type 2 diabetes, hypertension who presented to the emergency department chief concern of worsening abdominal pain along with nausea and vomiting. In the emergency department patient was positive for COVID. His GI symptoms were thought to be secondary to COVID infection. Patient also experienced a syncopal episode prior to his presentation which is most likely secondary to orthostatic hypotension and dehydration in the setting of GI losses. Cardiology was consulted to interrogate patient's ICD, which showed no significant abnormalities. At the time of admission CT abdomen was done which did not show acute abnormalities. However due to concern for AAA and repair history vascular surgery was consulted in the emergency department who reviewed the images of the CT abdomen and were concerned for infrarenal thrombus although this is not seen in the official CT abdomen read. Patient was started on IV heparin drip and Eliquis was placed on hold in case of procedure. CT abdomen pelvis repeated on 07/25 improved vascular surgery no intervention planned okay to transition back to Eliquis. Patient did well with COVID symptoms having no respiratory symptoms and improved diarrhea by the day of discharge. Patient was able to maintain hydration with po. In the emergency department patient was also found to have guaiac-positive stool test. GI was consulted and plan is to pursue outpatient colonoscopy and EGD. Plan is to continue Protonix 40 mg 2 times a day. Right upper quadrant ultrasound was consistent with hepatic steatosis. Patient was monitored for alcohol withdrawal and remained symptom-free. Patient with noted elevated bilirubin transaminases during hospital course that were improving by discharge. Discussion was had patient regarding need to have complete alcohol cessation. Recommend repeat CMP to follow within 1 week.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Aortic dissection Hyperlipidemia Hypertension Nonspecific abnormal electrocardiogram (ECG) (EKG) Status post aortic valve replacement Alcohol abuse Stage I (pT1, N0, M0) cecal cancer, S/p Hemicolectomy Acute gastroenteritis Hypovolemia AKI (acute kidney injury) Hypokalemia OSA (obstructive sleep apnea), mild to moderate Tobacco abuse Hypertrophic cardiomyopathy Genetic testing for HCM, inherited aortopathy, inherited cardiac arrhythmia (DO NOT EDIT) Prostate cancer Abdominal aortic aneurysm (AAA) Acute cystitis without hematuria Diet-controlled diabetes mellitus Stage 2 chronic kidney disease Vitamin D deficiency Permanent atrial fibrillation Senile nuclear cataract, bilateral Dry eyes, bilateral Presbyopia of both eyes Acute pharyngitis ICD (implantable cardioverter-defibrillator) in place Chronic kidney disease, stage 3a Syncope and collapse
- Andere Medikamente
- albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler apixaban (ELIQUIS) 5 MG tablet atorvastatin (LIPITOR) 80 MG tablet fluticasone (FLONASE) 50 MCG/ACT nasal spray folic acid (FOLVITE) 400 MCG tablet K
- Allergien
- CodeineShortness of Breath, Nausea and Vomiting, Unknown PenicillinsHives Sulfa DrugsUnknown
- Vorherige Impfungen
- -